TIL
10/03/2016 17:00
FORECAST
PRICE SENSITIVE
REL: 1700 HRS Trilogy International Limited
FORECAST: TIL: TIL outlines guidance for the FY to 31 March 2016
10 March 2016
Client Market Services
NZX Limited
by e-mail: [email protected]
Trilogy International Limited outlines guidance for the FY to 31 March 2016
Trilogy International Limited (NZX:TIL) Board wishes to announce a revision
to FY earnings expectations.
For the year to 31 March 2016, including the impact of the CS Company
acquisition, Trilogy expects revenue to exceed $83 million, increasing from
the previously released guidance of $75 million to $79 million.
Earnings before interest and tax (EBIT) are expected to exceed $14 million,
compared to prior guidance of $12 million to $14 million
The company expects net profit before tax (NPBT) to exceed $13 million,
compared to prior guidance of $10 million to $12 million.
The complete FY results will be released in May, including full commentary of
underlying performance and the expectation of FY17.
For more information:
Angela Buglass
Chief Executive Officer
+64 21 848 293
[email protected]
Geoff Ross Chairman
+64 21 42 219
[email protected]
About Trilogy International
Trilogy International (NZX:TIL) manufactures and distributes specialty
natural skin care and home fragrance products through three brands: Trilogy,
ECOYA and Goodness in New Zealand and around the world. Its recently acquired
subsidiary CS Company distributes international brands in New Zealand
including: Marc Jacobs; Calvin Klein; Dolce & Gabbana and Gucci fragrances
and Max Factor, Natio and OPI cosmetics and beauty brands.
For more information visit: http://trilogyproducts.com/investors/
End CA:00279099 For:TIL Type:FORECAST Time:2016-03-10 17:00:12
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
